Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8, Schott Reach Diagnostics Licensing Deal

NEW YORK (GenomeWeb News) – Accelr8 has granted Schott Technical Glass Solutions a license to sell its OptiChem-coated products for medical diagnostic applications.

The companies also renewed a license to Schott covering the German company's Nexterion microarray slides using OptiChem biocoatings. The renewal extends through Nov. 24, 2014.

The new medical diagnostics deal gives Schott the rights to sell up to 20,000 units of OptiChem-coated products per year to any single customer. If the customer exceeds that figure, Schott will refer the customer to Accelr8 to negotiate a direct license from the Denver-based firm.

Schott is paying Accelr8 a license fee of $150,000 and non-recourse pre-paid royalties. Schott will pay additional cash royalties to Accelr8 after Schott has met cumulative sales that generate the pre-paid royalty amount, the two firms said.

Accelr8 also has a licensing deal with Nanosphere in medical diagnostics.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.